Company Overview: NMUS

Industry News

7 Aug

NEMUS Bioscience Announces Presentation of CBD-analogue (NB2222) Ocular Data at the AAPS 2017 Annual Meeting

COSTA MESA, CA–(Marketwired – Aug 7, 2017) –   NEMUS Bioscience, Inc. ( OTCQB : NMUS ) announced that data recently obtained from the company’s research and development partner, the University of Mississippi (UM), will be presented at the American Association of Pharmaceutical Scientists (AAPS) meeting to be held in San Diego, CA on November 12-15,...

Read more

2 Aug

Nemus Bioscience Announces Presentation of NB2111 Analgesic and Anti-Addiction Data at NIH-Sponsored Cannabinoid Conference

COSTA MESA, CA–(Marketwired – Aug 2, 2017) – NEMUS Bioscience, Inc. ( OTCQB :NMUS ) announced that data recently obtained from the company’s research and development partner, the University of Mississippi (UM), will be presented on August 12that the Chemistry and Pharmacology of Drug Abuse Conference supported by the National Institute of Drug Abuse...

Read more

17 Jul

NEMUS Bioscience Announces NB2222 Pain and Anti-Addiction Data Accepted for Presentation at Upcoming Society of Neuroscience Meeting

COSTA MESA, CA–(Marketwired – Jul 17, 2017) – NEMUS Bioscience, Inc. ( OTCQB :NMUS ) announced that data recently obtained from the company’s research and development partner, the University of Mississippi (UM), was accepted for presentation at the 2017 Annual Meeting of the Society of Neuroscience held in Washington, D.C. on November 11th-15th. The data...

Read more

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address